AlphaStocks
5.1
Consider Buy

NEOGEN CORP (NEOG)

Health Care / Health Care Supplies

S&P SmallCap 600

$9.40

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#544out of 1127 in Health Care

Is NEOGEN CORP a Good Investment in 2026?

NEOGEN CORP (NEOG) scores 5.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating NEOGEN CORP as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 97%). NEOGEN CORP currently trades below its estimated fair value of $10, suggesting potential upside. NEOGEN CORP ranks #544 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-46.2Market Cap2B

Estimated Fair Value

$10.258% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Bottom half (rank 97%)

Frequently Asked Questions

Is NEOGEN CORP (NEOG) a good investment?
Based on AlphaStocks' composite analysis, NEOGEN CORP (NEOG) scores 5.1 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading near or slightly below estimated fair value.
What is NEOGEN CORP's Piotroski F-Score?
NEOGEN CORP's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is NEOG overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $10, NEOG appears undervalued. The stock currently trades 8% below its estimated fair value. Trading near or slightly below estimated fair value.
How does NEOG compare to other Health Care stocks?
NEOGEN CORP ranks #544 out of 1127 stocks in the Health Care sector, placing it in the top 48% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about NEOG?
AlphaStocks evaluates NEOG using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.1/10.

Similar Stocks

Compare NEOG with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer